JP2018515561A5 - - Google Patents

Download PDF

Info

Publication number
JP2018515561A5
JP2018515561A5 JP2017560566A JP2017560566A JP2018515561A5 JP 2018515561 A5 JP2018515561 A5 JP 2018515561A5 JP 2017560566 A JP2017560566 A JP 2017560566A JP 2017560566 A JP2017560566 A JP 2017560566A JP 2018515561 A5 JP2018515561 A5 JP 2018515561A5
Authority
JP
Japan
Prior art keywords
weight
composition
composition according
pharmaceutical emulsion
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017560566A
Other languages
English (en)
Japanese (ja)
Other versions
JP6863904B2 (ja
JP2018515561A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/052955 external-priority patent/WO2016185428A1/en
Publication of JP2018515561A publication Critical patent/JP2018515561A/ja
Publication of JP2018515561A5 publication Critical patent/JP2018515561A5/ja
Priority to JP2021062652A priority Critical patent/JP2021105027A/ja
Application granted granted Critical
Publication of JP6863904B2 publication Critical patent/JP6863904B2/ja
Priority to JP2023093301A priority patent/JP7531658B2/ja
Priority to JP2024122971A priority patent/JP2024153800A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017560566A 2015-05-21 2016-05-19 局所用医薬組成物 Active JP6863904B2 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2021062652A JP2021105027A (ja) 2015-05-21 2021-04-01 局所用医薬組成物
JP2023093301A JP7531658B2 (ja) 2015-05-21 2023-06-06 局所用医薬組成物
JP2024122971A JP2024153800A (ja) 2015-05-21 2024-07-30 局所用医薬組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562165097P 2015-05-21 2015-05-21
US62/165,097 2015-05-21
US201662324450P 2016-04-19 2016-04-19
US62/324,450 2016-04-19
PCT/IB2016/052955 WO2016185428A1 (en) 2015-05-21 2016-05-19 Topical pharmaceutical compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021062652A Division JP2021105027A (ja) 2015-05-21 2021-04-01 局所用医薬組成物

Publications (3)

Publication Number Publication Date
JP2018515561A JP2018515561A (ja) 2018-06-14
JP2018515561A5 true JP2018515561A5 (https=) 2019-06-27
JP6863904B2 JP6863904B2 (ja) 2021-04-21

Family

ID=56081527

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2017560566A Active JP6863904B2 (ja) 2015-05-21 2016-05-19 局所用医薬組成物
JP2021062652A Pending JP2021105027A (ja) 2015-05-21 2021-04-01 局所用医薬組成物
JP2023093301A Active JP7531658B2 (ja) 2015-05-21 2023-06-06 局所用医薬組成物
JP2024122971A Pending JP2024153800A (ja) 2015-05-21 2024-07-30 局所用医薬組成物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021062652A Pending JP2021105027A (ja) 2015-05-21 2021-04-01 局所用医薬組成物
JP2023093301A Active JP7531658B2 (ja) 2015-05-21 2023-06-06 局所用医薬組成物
JP2024122971A Pending JP2024153800A (ja) 2015-05-21 2024-07-30 局所用医薬組成物

Country Status (35)

Country Link
US (5) US10195160B2 (https=)
EP (2) EP4094752A1 (https=)
JP (4) JP6863904B2 (https=)
KR (2) KR20240090730A (https=)
CN (2) CN107666902B (https=)
AU (2) AU2016263161B2 (https=)
BR (1) BR112017024934A8 (https=)
CA (1) CA2986251A1 (https=)
CL (1) CL2017002939A1 (https=)
CO (1) CO2017011795A2 (https=)
CR (1) CR20170528A (https=)
CY (1) CY1125318T1 (https=)
DK (1) DK3297605T3 (https=)
DO (1) DOP2017000270A (https=)
EA (1) EA038624B1 (https=)
ES (1) ES2914112T3 (https=)
HR (1) HRP20220670T1 (https=)
HU (1) HUE059066T2 (https=)
IL (3) IL282304B2 (https=)
JO (1) JO3680B1 (https=)
LT (1) LT3297605T (https=)
MX (2) MX377629B (https=)
PE (1) PE20180038A1 (https=)
PH (1) PH12017502092A1 (https=)
PL (1) PL3297605T3 (https=)
PT (1) PT3297605T (https=)
RS (1) RS63402B1 (https=)
SG (1) SG11201708666RA (https=)
SI (1) SI3297605T1 (https=)
SM (1) SMT202200224T1 (https=)
TW (1) TWI705831B (https=)
UA (1) UA125500C2 (https=)
UY (1) UY36682A (https=)
WO (1) WO2016185428A1 (https=)
ZA (1) ZA202007965B (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11617724B2 (en) * 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
CN107666902B (zh) 2015-05-21 2021-09-21 德玛万科学有限责任公司 局部药物组合物
BR112020009158A2 (pt) 2017-11-10 2020-10-27 Dermavant Sciences GmbH processo para o preparo de um composto, composto e composição farmacêutica
CN109085257B (zh) * 2018-07-05 2021-04-06 中央民族大学 一种同时定量检测小鼠血浆中黄芪甲苷-iv、环黄芪醇的方法
MX368750B (es) * 2018-08-31 2019-10-15 Cell Therapy And Tech S A De C V Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular.
US11497718B2 (en) 2018-11-13 2022-11-15 Dermavant Sciences GmbH Use of tapinarof for the treatment of atopic dermatitis
JP6898622B2 (ja) * 2019-01-30 2021-07-07 学校法人神奈川大学 皮膚又は粘膜の外用剤及びその製造方法、並びに皮膚又は粘膜の外用剤の基剤
WO2020214855A1 (en) 2019-04-17 2020-10-22 Azora Therapeutics, Inc. Topical compositions and methods for treating inflammatory skin diseases
AU2020275208B2 (en) * 2019-05-15 2025-12-04 Leo Pharma A/S Formulation of delgocitinib in the form of a cream
US20200383887A1 (en) * 2019-06-04 2020-12-10 L'oreal Oxygenate skin treatment system
CA3144947A1 (en) * 2019-06-26 2020-12-30 Locus Oil Ip Company, Llc Multi-functional compositions comprising concentrated acids for enhanced oil and gas recovery
MX2022000960A (es) * 2019-07-24 2022-03-22 Sol Gel Tech Ltd Tratamiento de trastornos de la piel con composiciones topicas de tapinarof-inhibidor de egfr.
WO2021059281A1 (en) * 2019-09-26 2021-04-01 Sol-Gel Technologies Ltd. Treatment of skin disorders with topical combination compositions comprising tapinarof and an additional ahr activator
WO2021059283A1 (en) * 2019-09-26 2021-04-01 Sol-Gel Technologies Ltd. Treatment of cutaneous adverse effects caused by oncological therapy with topical tapinarof compositions
CA3160126A1 (en) * 2019-11-06 2021-05-14 Sol-Gel Technologies Ltd. Method of treating palmoplantar keratoderma
US20230000786A1 (en) * 2019-11-24 2023-01-05 Sol-Gel Technologies Ltd. Treatment of skin disorders with topical compositions comprising tapinarof and a pde4 inhibitor
GB202000167D0 (en) 2020-01-07 2020-02-19 Cytovation As Composition for treatment of neoplastic lesions
US11154486B2 (en) 2020-02-14 2021-10-26 William M. Yarbrough Foundation Detergent compositions for washing urushiol and methods of treating urushiol induced contact dermatitis
US11191708B2 (en) * 2020-02-17 2021-12-07 William M. Yarbrough Foundation Sodium lauroyl sarcosinate containing detergent compositions
WO2021262917A1 (en) * 2020-06-24 2021-12-30 Dermavant Sciences GmbH Topical pharmaceutical compositions
CA3186628A1 (en) * 2020-06-30 2022-01-06 Dermira, Inc. Ror.gamma.t inhibitors and topical uses thereof
US12440529B2 (en) 2020-09-22 2025-10-14 Alphyn Biologics, Inc. Topical Croton lechleri compositions and their use in the treatment of a bacterial colonization or primary or secondary bacterial infection of an underlying skin disorder
JP2023550085A (ja) * 2020-11-23 2023-11-30 ダーマバント、サイエンシーズ、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング タピナロフのゲル、軟膏、およびフォーム製剤ならびに使用方法
CA3208742A1 (en) * 2021-02-17 2022-08-25 David Scott Rubenstein Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis
JP2024508454A (ja) 2021-02-25 2024-02-27 アルフィン バイオロジックス、エルエルシー 局所皮膚細菌性皮膚疾患治療用組成物
CN113797159A (zh) * 2021-10-22 2021-12-17 冠昊生物科技股份有限公司 一种本维莫德乳膏剂及其制备方法和用途
JP2025529076A (ja) * 2022-08-30 2025-09-04 ダーマヴァント サイエンシーズ ゲーエムベーハー ＡｈＲ媒介疾患の治療に使用するタピナロおよびそのアナログ製剤
WO2024124206A1 (en) * 2022-12-08 2024-06-13 Hairdao Payments Llc Topical compositions for treating and preventing hair loss and hair graying
WO2025031935A1 (en) 2023-08-04 2025-02-13 Sandoz Ag Crystalline forms of tapinarof

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5111748A (en) 1974-07-16 1976-01-30 Taisho Pharmaceutical Co Ltd Suchirubenjudotaino seizoho
US4048310A (en) 1976-02-24 1977-09-13 E. R. Squibb & Sons, Inc. Topical steroid formulation in form of lotion or cream
JPS58159410A (ja) 1982-03-18 1983-09-21 Mitsubishi Chem Ind Ltd 抗炎症剤
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
US5008100A (en) 1989-08-11 1991-04-16 Elizabeth Arden Co., Division Of Conopco, Inc. Oil-in-water emulsions containing polyethylene
US6113921A (en) * 1993-03-23 2000-09-05 Pharmos Corp. Topical and transdermal delivery system utilizing submicron oil spheres
AU7513994A (en) 1993-07-27 1995-02-28 Agro-Biotech Corporation Novel fungicidal properties of metabolites, culture broth, stilbene derivatives and indole derivatives produced by the bacteria (xenorhabdus) and (photorhabdus) spp.
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
JPH1072330A (ja) 1996-09-03 1998-03-17 Kansai Kouso Kk チロシナーゼ活性阻害剤及び化粧料
JPH1143436A (ja) * 1997-07-25 1999-02-16 Showa Denko Kk 末梢血流障害予防・治療剤
EP0985404A4 (en) 1998-02-10 2002-07-31 Shiseido Co Ltd AQUEOUS TYPE EMULSIONATED COMPOSITION
SE9800729L (sv) 1998-03-06 1999-09-07 Scotia Lipidteknik Ab Ny topikal formulering I
FR2777183B1 (fr) 1998-04-10 2001-03-02 Oreal Utilisation d'au moins un hydroxystilbene dans une composition destinee a favoriser la desquamation de la peau et composition le comprenant
AU4084599A (en) 1998-05-18 1999-12-06 Oklahoma Medical Research Foundation Resveratrol inhibition of myeloperoxidase
DE19842730A1 (de) * 1998-09-18 2000-03-23 Beiersdorf Ag Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl
FR2785284B1 (fr) 1998-11-02 2000-12-01 Galderma Res & Dev Analogues de la vitamine d
US6761903B2 (en) * 1999-06-30 2004-07-13 Lipocine, Inc. Clear oil-containing pharmaceutical compositions containing a therapeutic agent
US20020054895A1 (en) * 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
US7321050B2 (en) 1999-12-06 2008-01-22 Welichem Biotech Inc. Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues
DE60043120D1 (de) 1999-12-06 2009-11-19 Welichem Biotech Inc Polyhydroxystilbene und -stilbenoxide als antipsoriasismittel und proteinkinasehemmer
FR2811564B1 (fr) 2000-07-13 2002-12-27 Oreal Nanoemulsion contenant des polymeres non ioniques, et ses utilisations notamment dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
DE10036871A1 (de) * 2000-07-28 2002-02-14 Pharmasol Gmbh Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
EP1368306B1 (en) 2001-01-18 2013-01-16 Welichem Biotech Inc. Novel 1,2-diphenylethene derivatives for treatment of immune diseases
US20030073712A1 (en) 2001-07-23 2003-04-17 Bing Wang Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
RU2212763C2 (ru) * 2001-08-16 2003-09-20 Общество с ограниченной ответственностью "Подсолнечник Технологии" Система открытой оптической связи
MXPA04008818A (es) * 2002-03-12 2004-11-26 Playtex Products Inc Composiciones de locion.
US20040202634A1 (en) * 2003-03-19 2004-10-14 L'oreal Composition useful for cosmetic or dermatological use containing a block copolymer
AP2006003784A0 (en) 2004-03-18 2006-10-31 Panacea Biotec Ltd Novel compositions for topical delivery
US20060018861A1 (en) * 2004-07-23 2006-01-26 Minghua Chen Skin care composition
DE602005008635D1 (de) * 2004-10-19 2008-09-11 Boots Co Ltd Kosmetische zusammensetzungen
US20060246098A1 (en) * 2005-03-16 2006-11-02 Srinivasa Rao Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same
KR20070057660A (ko) * 2005-12-01 2007-06-07 롬 앤드 하아스 컴패니 활성물을 안정시키기 위한 수성 폴리머 분산액
FR2898498B1 (fr) * 2006-03-15 2008-11-28 Galderma Sa Nouvelles compositions topiques sous forme d'emulsion h/e comprenant un glycol pro-penetrant
EP2073794A2 (en) * 2006-11-14 2009-07-01 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
EP1930499A1 (en) * 2006-12-08 2008-06-11 Cognis IP Management GmbH Tissue paper comprising a softening lotion
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
US9308239B2 (en) 2008-02-26 2016-04-12 The Penn State Research Foundation Methods and compositions for treatment of retinoid-responsive conditions
JP2011518844A (ja) * 2008-04-25 2011-06-30 ナノバイオ コーポレーション 真菌、酵母および糸状菌感染症を治療するためのナノエマルション
JP2009291133A (ja) * 2008-06-05 2009-12-17 Snow Brand Milk Prod Co Ltd チーズ食品
CN102438590B (zh) * 2009-02-25 2013-07-10 施泰福研究澳大利亚有限公司 局部泡沫组合物
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
CN101822638A (zh) * 2009-12-01 2010-09-08 河北科技大学 二苯乙烯类化合物的纳米乳及其制备方法
US20130303495A1 (en) * 2009-12-31 2013-11-14 Sov Therapeutics Emulsion formulations
CA2790827A1 (en) * 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
MX2013004296A (es) * 2010-10-21 2013-09-26 Cadila Healthcare Ltd Composiciones farmaceuticas topicas que contienen gotas de tamaño nanometrico para el tratamiento de soriasis.
JP6030067B2 (ja) 2010-12-03 2016-11-24 アラーガン、インコーポレイテッドＡｌｌｅｒｇａｎ，Ｉｎｃｏｒｐｏｒａｔｅｄ 薬学的クリーム組成物および使用法
CN107012201A (zh) 2011-06-27 2017-08-04 高德美研究及发展公司 用于痤疮的新th17分化标志物及其用途
US20130224268A1 (en) 2012-02-27 2013-08-29 Newgen Biopharma Corp. Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same
CN102657610A (zh) 2012-05-11 2012-09-12 河北科技大学 3,5-二羟基-4-异丙基二苯乙烯微乳剂及其制备方法
CN102657602B (zh) 2012-05-22 2013-08-07 河北科技大学 3,5-二羟基-4-异丙基二苯乙烯壳聚糖凝胶剂及其制备方法
US9433680B2 (en) * 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
CN103315958B (zh) 2013-07-19 2014-10-29 河北科技大学 苯烯莫德纳米乳及其制备方法
US9925153B2 (en) 2013-12-06 2018-03-27 Stc.Unm Therapeutic agents for skin diseases and conditions
CN103992212B (zh) * 2014-05-29 2015-07-01 河北科技大学 顺式苯烯莫德的合成方法及顺式苯烯莫德的应用
EP3229840B1 (en) 2014-12-12 2020-09-09 Dermavant Sciences GmbH 3,5-dihydroxy-4-isopropyl-trans-stilbene for use in the topical treatment of acne
CN107666902B (zh) 2015-05-21 2021-09-21 德玛万科学有限责任公司 局部药物组合物
US11617724B2 (en) 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
BR112020009158A2 (pt) 2017-11-10 2020-10-27 Dermavant Sciences GmbH processo para o preparo de um composto, composto e composição farmacêutica

Similar Documents

Publication Publication Date Title
JP2018515561A5 (https=)
IL282304B1 (en) Topical pharmaceutical emulsion compositions comprising 3,5-dihydroxy-4-isopropyl-trans-stilbene and use thereof in the treatment or prophylaxis of ermatological conditions or disorders
JP5465011B2 (ja) 少なくとも１種のレチノイドおよび過酸化ベンゾイルを含むエマルジョン
JP2016515525A5 (https=)
KR20170110083A (ko) 경피 투여를 위한 방법 및 제형
US20090010968A1 (en) Spot-on formulation useful for cosmetology and dermatology
US9629785B2 (en) Pharmaceutical compositions comprising nano size droplets of skin whitening agents
KR20110027838A (ko) 광선 각화증을 치료하기 위한 국소 조성물
US20050137164A1 (en) Diclofenac compositions for the treatment of skin disorders
JP2023550085A (ja) タピナロフのゲル、軟膏、およびフォーム製剤ならびに使用方法
WO2016104618A1 (ja) 医療用皮膚外用剤
JP3814224B2 (ja) 外用組成物
JP2021008450A (ja) 角層修復促進剤
JP2008273941A (ja) アダパレン含有外用剤組成物
JPWO2019082873A1 (ja) 被膜形成外用剤
JP7446711B2 (ja) 皮膚外用組成物
JP5695310B2 (ja) γ−オリザノール含有外用剤組成物
JP2017214343A (ja) 尋常性ざ瘡治療剤
NZ736602B2 (en) Topical pharmaceutical compositions
JP2006511547A (ja) 塩基を使用する、溶媒中における可溶化レチノイドの化学的安定化方法
JP6084579B2 (ja) タクロリムスを含有する水中油型クリーム状組成物
JP7610359B2 (ja) 外用組成物
JP5980171B2 (ja) アダパレン含有外用剤組成物
ES2836814T3 (es) Un perfluoropoliéter para su uso en tratamientos de fototerapia cutánea
EP4327824A1 (en) A topical composition comprising chlorine e6 and zinc l-pyroglutamate